Last quarter (Q ), Meridian Bioscience's total revenue was $65.67M, a decrease of -13.82% from the same quarter last year. In Q, Meridian Bioscience's net income was $5.71M. See Meridian Bioscience’s key income statements, including revenue, expenses, profit, and income.

Income Statement	TTM	Sep 22	Sep 21	Sep 20	Sep 19	Sep 18
Total Revenue	$ 333.02M	$ 333.02M	$ 317.90M	$ 253.67M	$ 201.01M	$ 213.57M
Cost of Revenue	$ 144.66M	$ 144.66M	$ 116.75M	$ 97.42M	$ 82.29M	$ 82.54M
Gross Profit	$ 188.36M	$ 188.36M	$ 201.15M	$ 156.25M	$ 118.73M	$ 131.03M
Operating Expense	$ 113.19M	$ 112.41M	$ 107.63M	$ 96.64M	$ 81.38M	$ 90.74M
Operating Income	$ 75.16M	$ 75.95M	$ 93.52M	$ 59.61M	$ 37.35M	$ 40.29M
Net Non Operating Interest Income Expense	$ -1.17M	$ -1.17M	$ -1.88M	$ -2.49M	$ -1.26M	$ -1.10M
Other Income Expense	$ -19.67M	$ -20.46M	$ -1.19M	$ 2.17M	$ -4.53M	$ -8.81M
Pretax Income	$ 54.32M	$ 54.32M	$ 90.45M	$ 59.29M	$ 31.56M	$ 30.38M
Tax Provision	$ 11.86M	$ 11.86M	$ 19.04M	$ 13.11M	$ 7.17M	$ 6.53M
Earnings From Equity Interest Net Of Tax	-	-	-	-	-	-
Net Income Common Stockholders	$ 42.46M	$ 42.46M	$ 71.41M	$ 46.19M	$ 24.38M	$ 23.85M
Basic EPS	$ 0.97	$ 0.97	$ 1.65	$ 1.08	$ 0.57	$ 0.56
Diluted EPS	$ 0.96	$ 0.96	$ 1.62	$ 1.07	$ 0.57	$ 0.56
Basic Average Shares	$ 174.33M	$ 43.58M	$ 43.26M	$ 42.85M	$ 42.57M	$ 42.33M
Diluted Average Shares	$ 177.57M	$ 44.38M	$ 44.01M	$ 43.17M	$ 42.90M	$ 42.75M
Dividend Per Share	-	$ 0.00	$ 0.00	$ 0.00	$ 0.25	$ 0.50
Total Operating Income As Reported	-	-	-	-	-	-
Reported Normalized Basic E P S	$ 0.21	$ 1.40	$ 1.69	$ 1.08	$ 0.68	$ 0.75
Reported Normalized Diluted E P S	$ 0.20	$ 1.38	$ 1.66	$ 1.07	$ 0.68	$ 0.74
Rent Expense Supplemental	-	-	-	-	-	-
Total Expenses	$ 257.86M	$ 257.07M	$ 224.38M	$ 194.06M	$ 163.67M	$ 173.28M
Net Income From Continuing And Discontinued Operation	$ 42.46M	$ 42.46M	$ 71.41M	$ 46.19M	$ 24.38M	$ 23.85M
Normalized Income	$ 54.93M	$ 59.32M	$ 71.00M	$ 44.85M	$ 27.97M	$ 30.68M
Interest Expense	$ 1.19M	$ 1.19M	$ 1.88M	$ 2.63M	$ 1.95M	$ 1.52M
EBIT	$ 55.51M	$ 55.51M	$ 92.33M	$ 61.92M	$ 33.50M	$ 31.90M
EBITDA	$ 72.02M	$ 72.02M	$ 107.61M	$ 75.49M	$ 43.47M	$ 39.82M

Currency in USD

Meridian Bioscience Earnings and Revenue History

Get More with TipRanks Premium

What's Included in PREMIUM?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing